Pharmacokinetic Changes of Psychotropic Drugs in Patients with Liver Disease: Implications for Dose Adaptation

By Schlatter Chantal   Egger Sabin S.   Tchambaz Lydia   Krähenbühl Stephan  

Drug Safety, Vol. 32, Iss. 7, 2009-07 ,pp. : 561-578

Adis International

Access to resources Recommend Favorite

The Role of Pharmacogenetics in the Metabolism of Antiepileptic Drugs: Pharmacokinetic and Therapeutic Implications

By Klotz Ulrich  

Clinical Pharmacokinetics, Vol. 46, Iss. 4, 2007-01 ,pp. : 271-279

Adis International

Access to resources Recommend Favorite

Neurotransmitters, Psychotropic Drugs and Microglia: Clinical Implications for Psychiatry

By  

Current Medicinal Chemistry, Vol. 20, Iss. 3, 2013-01 ,pp. : 331-344

Bentham Science Publishers

Access to resources Recommend Favorite

Neonatal Exposure to Drugs in Breast Milk

By McNamara Patrick J.   Abbassi Maggie  

Pharmaceutical Research, Vol. 21, Iss. 4, 2004-04 ,pp. : 555-566

Springer Publishing Company

Access to resources Recommend Favorite

Metabolism of the Newer Antidepressants: An Overview of the Pharmacological and Pharmacokinetic Implications

By Caccia S.  

Clinical Pharmacokinetics, Vol. 34, Iss. 4, 1998-04 ,pp. : 281-302

Adis International

Access to resources Recommend Favorite